Systemic Autoimmunity and Lymphoproliferation Are Associated with Excess IL-7 and Inhibited by IL-7Rα Blockade by Gonzalez-Quintial, Rosana et al.
Systemic Autoimmunity and Lymphoproliferation Are
Associated with Excess IL-7 and Inhibited by IL-7Ra
Blockade
Rosana Gonzalez-Quintial
1, Brian R. Lawson
1, John C. Scatizzi
1, Joseph Craft
2, Dwight H. Kono
1, Roberto
Baccala
1*
., Argyrios N. Theofilopoulos
1*
.
1Department of Immunology and Microbial Science, The Scripps Research Institute, La Jolla, California, United States of America, 2Department of Immunobiology and
Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut, United States of America
Abstract
Lupus is characterized by disturbances in lymphocyte homeostasis, as demonstrated by the marked accumulation of
activated/memory T cells. Here, we provide evidence that proliferation of the CD8
+ precursors for the accumulating
CD4
–CD8
– T cells in MRL-Fas
lpr lupus-predisposed mice is, in part, driven by commensal antigens. The ensuing
lymphadenopathy is associated with increased production of IL-7 due to expansion of fibroblastic reticular cells, the primary
source of this cytokine. The excess IL-7 is not, however, consumed by CD4
–CD8
– T cells due to permanent down-regulation
of IL-7Ra (CD127), but instead supports proliferation of autoreactive T cells and progression of autoimmunity. Accordingly,
IL-7R blockade reduced T cell activation and autoimmune manifestations even when applied at advanced disease stage.
These findings indicate that an imbalance favoring production over consumption of IL-7 may contribute to systemic
autoimmunity, and correction of this imbalance may be a novel therapeutic approach in lymphoproliferative and
autoimmune syndromes.
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Introduction
Lupus, the archetypal systemic autoimmune disease, is charac-
terized by a broad array of T and B cell abnormalities and a
plethora of autoantibodies, among which those directed against
nucleosomal (DNA, histones) and spliceosomal (small nuclear
ribonucleoproteins, snRNP) antigens predominate. Consequent to
chronic immune system activation and the effects of various
autoantibodies, lupus is characterized by an expedited accumula-
tion of activated T cells as well as lymphopenia, both implying
severe disturbances in lymphocyte homeostasis. These disturbanc-
es may be attributed to a constellation of factors, including the
continuous T cell activation by the ever-present self-antigens,
defective activation-induced cell death, and excess of cytokines
that promote T cell activation and/or survival. The contribution
of these factors may depend on the genetic defect(s) that underlies
the pathogenic predisposition. These issues can best be addressed
in murine strains that spontaneously develop lupus-like systemic
autoimmunity. Among these, the MRL-Fas
lpr model exhibits the
most evident disturbance in lymphocyte homeostasis due to an
early retroviral transposon insertion in the gene encoding the
apoptosis-mediating Fas protein, resulting in defective activation-
induced cell death and accumulation of activated/memory T cells.
Recent studies have considerably advanced our understanding
of the mechanims by which normal T cell homeostasis is
controlled, with two cytokines, IL-7 and IL-15, playing primary
roles [1,2]. IL-7 is mostly produced by fibroblastic reticular cells
(FRCs), a mesenchymal cell population found in the stromal
environment of lymphoid organs [3,4]. Binding of IL-7 to the IL-7
receptor (IL-7R), composed of the IL-7Ra chain (CD127) and the
common cytokine c chain (cc, CD132), activates several signaling
pathways that enhance cellular metabolic functions and survival of
naı ¨ve, early effector and memory CD4
+ and CD8
+ T cells,
primarily by inducing anti-apoptotic Bcl-2 family members [5].
Similarly, IL-15, primarily expressed by activated monocytes and
dendritic cells, binds to IL-15Ra (CD359) on accessory cells and is
trans-presented to T cells expressing a functional IL-15R,
composed of IL-2/15Rb (CD122) and cc chains [6]. IL-15
promotes the long-term survival of memory CD8
+ T cells and, in
part, naı ¨ve CD8
+ and memory CD4
+ T cells, but cannot fully
compensate for the requirement of IL-7 [1].
In contrast to physiologic conditions in which the availability of
IL-7 and IL-15 is rather limited, surplus of these cytokines caused
by either reduced consumption (as in lymphopenic mice) or
increased production (as in transgenic mice) induces a self-MHC/
peptide-dependent T cell expansion, referred to as ‘‘homeostatic
proliferation’’, that ceases only when the equilibrium between
cytokine levels and T cell numbers is reestablished [1,2]. Although
largely polyclonal, homeostatic proliferation appears to favor
expansion of T cell clones with higher affinity for self-peptides
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with conventional antigen-induced activation [9,10] and even
effector functions [11–13]. We and others, therefore, proposed
that continuous or recurrent lymphopenia and the associated
cytokine excess may promote the preferential activation and
expansion of self-reactive T cells and autoimmunity in predisposed
individuals [14–17].
In addition to slow-paced homeostatic proliferation occurring
under conditions of acute lymphopenia, a second fast-paced form
of proliferation termed ‘‘spontaneous proliferation’’ has been
observed upon T cell transfer in mice that are chronically
lymphopenic due to the absence of recombination activating genes
(RAG1 or RAG2) or T cell receptor-encoding genes (TCRa or
TCRb) [18]. In contrast to homeostatic proliferation, spontaneous
proliferation does not require IL-7 and is likely driven by
commensal rather than self-antigens since it is significantly
reduced in germ-free recipients [19-21].
Here, we report that both spontaneous and homeostatic
proliferation coexist in the MRL-Fas
lpr lupus model. The origin
of this homeostasis disturbance could be attributed to self and
commensal antigen-induced lymphadenopathy, resulting in ex-
pansion of IL-7-producing FRCs and down-regulation of IL-7R in
chronically activated T cells. These changes culminate in an excess
of IL-7 that sustains the autoimmune process and, thus, blockade
of IL-7R signaling significantly decreased disease manifestations in
this model.
Results
A Subset of MRL-Fas
lpr T Cells Exhibit Phenotypic Markers
of Homeostatic Proliferation
In autoimmunity, T cell activation might be induced by either
conventional antigen-mediated engagement or excess of T cell
trophic cytokines and homeostatic proliferation. These two types
of activation can be distinguished by differences in phenotypic cell
surface markers, as cognate antigen-activated T cells are
CD44
hiCD69
+CD25
+CD62L
low, whereas homeostatically-ex-
panded T cells are CD44
hiCD69
–CD25
–CD62L
hi [9,22]. As
previously described [23], with age and disease progression, MRL-
Fas
lpr mice exhibited a moderate expansion of lymph node (LN)
CD4
+ and CD8
+ single-positive (SP) T cells, and a much larger
expansion of CD4
–CD8
– double-negative (DN) T cells (Figure 1A).
Interestingly, substantial fractions of SP and DN T cells expressed
high levels of CD44 and CD62L, but lacked expression of CD25
and CD69, suggesting that their expansion was caused by excess of
T cell-trophic cytokines (Figure 1B). This interpretation is further
supported by the finding that most CD25
+ T cells (99.160.1% in
young and 96.560.9% in old MRL-Fas
lpr mice) were CD4
+Foxp3
+
regulatory T cells. However, ,50% of CD4
+ and DN T cells, and
,25% of CD8
+ T cells in LNs of older mice were CD69
hi,
indicating a concurrent conventional self or foreign antigen-driven
activation. These findings suggest that both conventional antigen-
mediated engagement and homeostatic proliferation contribute to
T cell activation in MRL-Fas
lpr mice.
DN T Cells Lack Receptors for IL-7 and IL-15
Because T cell survival and homeostatic proliferation are
dependent on signaling by IL-7 and IL-15, we examined the
expression profiles of the receptors for these cytokines. Depending
on age, 45–61% of CD4
+ T cells and 85–87% of CD8
+ T cells in
spleen and LNs expressed high levels of IL-7Ra, while 43–75% of
CD8
+ T cells, but only 2–4% CD4
+ T cells, expressed IL-2/15Rb
(Figure 2A), frequencies similar to those in normal mice.
Strikingly, however, virtually all DN T cells lacked both these
receptors, particularly at advanced age (Figure 2A). Accordingly,
in vitro survival of CD4
+ and CD8
+ T cells was markedly
enhanced by IL-7, whereas DN T cells were unaffected by this
cytokine (Figure 2B). Moreover, as previously reported for normal
T cells [24], IL-7Ra was down-regulated on both CD4
+ and CD8
+
T cells cultured in the presence of IL-7 and up-regulated in the
absence of this cytokine, but receptor expression remained
undetectable on DN T cells in either condition (Figure 2C),
suggesting that IL-7Ra is irreversibly down-regulated on DN T
cells. Since most DN T cells are thought to derive from CD8
+
precursors [25-31], we next examined the effects of IL-15 and IL-
21, two cytokines known to support survival and proliferation of
naı ¨ve and memory CD8
+ T cells [6,32]. Consistent with IL-2/
15Rb expression, IL-15 enhanced the in vitro survival of CD8
+,
but not DN, T cells. In contrast, IL-21 significantly enhanced
survival of DN T cells (Figure 2D, upper and middle panels)
without inducing proliferation (Figure 2D, lower panel), an effect
that correlated with expression of both IL-21R chains (a and cc)
by these cells (Figure 2A). These results indicate that DN T cells
lose IL-7Ra and IL-2/15Rb, cease using IL-7 and IL-15, and
switch to alternative survival resources, such as IL-21.
Commensal Antigens May Contribute to Conversion of
CD8
+ Precursors to DN T Cells
Persistent down-regulation of IL-7Ra and IL-2/15Rb has been
observed on T cells undergoing extensive activation and reaching
a functionally defined ‘‘exhausted’’ state [33,34]. Although
accumulation of DN T cells in MRL-Fas
lpr mice is due to defective
Fas-mediated apoptosis, the nature of the antigens (self or foreign)
that drive activation of the CD8
+ precursors for DN cells has not
been defined. To differentiate between self and foreign stimuli,
experiments were performed with purified, LN-derived T cell
subsets transferred into TCRb
–/– MRL-Fas
lpr recipients. In these
chronically immunodeficient hosts, T cells with slow division,
defined as ‘‘homeostatic proliferation’’, are thought to respond to
self-peptide/MHC ligands, whereas those with rapid division,
defined as ‘‘spontaneous proliferation’’, are thought to proliferate
in an IL-7-independent manner [18], likely in response to
microbiota-derived ligands [19–21]. As observed in chronically
T cell-deficient normal background mice, at 1 week post-transfer
of syngeneic T cells into TCRb
-/- MRL-Fas
lpr recipients, ,14% of
CD4
+ T cells recovered from peripheral LNs (a pool of inguinal,
brachial and axillary) had undergone slow-paced homeostatic
proliferation (1 to 7 divisions) and ,68% fast-paced spontaneous
proliferation (.7 divisions) (Figure 3A). Remarkably, however, the
vast majority of CD8
+ T cells (83%) exhibited homeostatic
proliferation, whereas DN T cells showed the opposite, i.e. almost
exclusively spontaneous proliferation (Figure 3A). At 2 weeks post-
transfer, spontaneous proliferation of CD8
+ T cells was more
evident, particularly in mesenteric LNs, the primary site of
commensal antigen recognition [19,20], and in spleen, but
remained significantly lower than spontaneous proliferation of
control CD8
+ T cells from C57BL/6 mice transferred into
chronically immunodeficient (RAG2
–/–) syngeneic recipients
(Figure 3B).
The reduced spontaneous proliferation of MRL-Fas
lpr CD8
+ T
cells was not due to lack of CD4
+ T cells or competition with other
cell types such as NK and cd T cells, since slow division of CD8
+ T
cells was maintained when total LN cells were transferred into
sublethally-irradiated TCRb
–/– recipients. Instead, reduced spon-
taneous proliferation could be due to conversion of CD8
+ T cells
to DN cells. Indeed, a significant proportion (,51–82%) of the
CD8
+ T cells that had undergone .7 divisions in LNs of TCRb
–/–
recipients converted to DN T cells (Figure 3C) and down-
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only 3–9% of CD4
+ T cells that had undergone .7 divisions
converted to DN T cells. Interestingly, this conversion was not
observed in T cells undergoing slow-paced homeostatic prolifer-
ation (Figure 3C and 3D). Hence, the evidence provided by these
experiments is compatible with the possibility that recognition of
commensal antigens leads to strong proliferation of CD8
+ T cells,
which is associated with down-regulation of both the CD8
coreceptor and the receptors for major T cell trophic cytokines.
Accumulation of DN T Cells Leads to Excess IL-7
Down-regulation of IL-7Ra should make DN T cells inefficient
consumers of trophic cytokines and therefore unable to inhibit
homeostatic proliferation of SP T cells. Moreover, reduced
consumption by these cells might create an excess of IL-7
sufficient to provoke proliferation of T cells under non-lympho-
penic conditions. Indeed, homeostatic proliferation of CFSE-
stained MRL-Fas
lpr SP T cells in LNs of TCRb
–/– recipients was
not inhibited by co-transfer of large numbers (100 6 10
6)o f
purified DN T cells (Figure 4A). In contrast, efficient inhibition
was achieved by co-transfer of total LN cells (50 6 10
6) from
young MRL-Fas
lpr donors, which are mostly composed of naı ¨ve T
cells with minimal DN T cell expansion (Figure 4A). More
importantly, a significant fraction of SP T cells proliferated when
transferred into unmanipulated (non-lymphopenic) older MRL-
Fas
lpr mice with lymphadenopathy and DN T cell expansion
(Figure 4B), whereas no significant proliferation was detected in
non-lymphopenic younger MRL-Fas
lpr mice with no lymphade-
nopathy (Figure 4C). Interestingly, this proliferation was IL-7-
dependent and could be inhibited with an anti-IL-7Ra antibody
(Figure 4D). These findings indicate that, in parallel with the
accumulation of DN T cells lacking IL-7Ra, older MRL-Fas
lpr
mice develop excess of IL-7 of sufficient magnitude to induce
activation and expansion of potentially autoreactive T cells.
Lymphadenopathy is Associated with Expansion of IL-7-
Producing Stromal Cells
Because lymphadenopathy may also lead to the expansion of
cells that produce IL-7, we examined IL-7 expression as well as
frequency of fibroblastic reticular cells (FRCs), the major
producers of this cytokine in secondary lymphoid organs [3]. IL-
7 transcripts were significantly increased in the enlarged LNs of
older MRL-Fas
lpr mice (Figure 5A), while IL-7Ra transcripts were
decreased, resulting in ,7-fold higher ratio of IL-7 to IL-7Ra
expression in older compared to younger mice (Figure 5A).
Similarly, higher IL-7 protein levels were detected in LNs from
older MRL-Fas
lpr mice compared to younger MRL-Fas
lpr mice or
C57BL/6 controls (Figure 5B). These findings correlated with an
,7.6-fold increase in the ratio between the numbers of FRCs and
IL-7Ra
+ T cells (Figure 5C-5D). Furthermore, analysis of MRL-
Fas
lpr mice with various degrees of lymphadenopathy indicated
that FRCs accumulated proportionally to the number of total LN
cells, whereas IL-7Ra
+ T cells accumulated at much slower rate
(Figure 5E). Thus, excess of IL-7 in MRL-Fas
lpr mice is caused by a
combination of decreased consumption due to receptor down-
regulation by DN T cells, and increased production due to FRC
expansion.
Anti-IL-7Ra Antibody Treatment Reduces Disease in MRL-
Fas
lpr Mice
Since excess of IL-7 signaling may decrease the activation
threshold and provoke proliferation of autoreactive T cells, we
examined whether blockade of IL-7R could exert therapeutic
effects in the MRL-Fas
lpr disease. Initial experiments showed that
an anti-IL-7Ra monoclonal antibody (A7R34, rat IgG2a) [35]
effectively blocked this receptor in vivo (Figure 6A), and
inhibited IL-7-mediated STAT5 phosphorylation in vitro (mean
fluorescence intensity for p-STAT5 in CD4
+ Tc e l l s :2 9 5 65f o r
non-stimulated cells, 587634 for cells treated with IL-7, and
Figure 1. Lymphoaccumulation and T cell phenotype in MRL-Fas
lpr mice. (A) T cell accumulation. LN cells were obtained from MRL-Fas
lpr and
control C57BL/6 mice at the indicated ages. Frequency and number (6 SD) of CD4
+, CD8
+ and DN T cells were determined by flow cytometry after
gating on the TCRb
+ cell population. (B) T cell phenotype. Expression of CD44, CD69, CD25 and CD62L by TCRb
+CD4
+, TCRb
+CD8
+, and TCRb
+DN T
cells was assessed by flow cytometry in LNs of young (Y, 8 weeks of age) and older (O, 12 weeks of age) MRL-Fas
lpr mice. Numbers indicate
percentage of positive cells (6 SD). Data are representative of 3–10 independent experiments with 3–5 mice/group.
doi:10.1371/journal.pone.0027528.g001
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lpr T cells. (A) IL-7Ra and IL-2/15Rb down-regulation in DN T cells. Lymph
node T cells from young (8 weeks of age) and older (12 weeks) MRL-Fas
lpr mice were analyzed for expression of IL-7Ra (CD127), IL-15Rb (CD122), cc
(CD132) and IL-21R. Numbers indicate percentage of positive cells (6 SD). Similar profiles were obtained with spleen cells. (B) Effect of IL-7 on T cell
survival. Aliquots (5610
6) of LN cells were cultured with or without IL-7 (20 ng/ml), and numbers (6 SD) of viable CD4
+, CD8
+ and DN T cells were
determined at the indicated time-points by cell counting upon Trypan Blue staining and flow cytometry. (C) Permanent IL-7Ra down-regulation in DN
T cells. LN cells (5610
6) from MRL-Fas
lpr mice (20 weeks of age) were analyzed either ex vivo, or after 24 hr in vitro culture in the presence of absence
of IL-7 (20 ng/ml). (D) Effect of IL-21 on DN T cell survival. DN T cells (5610
6) were purified from LNs and cultured for 3 days in medium (control, C), or
in the presence of IL-7 (20 ng/ml), IL-15 (10 ng/ml) or IL-21 (50 ng/ml, upper panel; 50-200 ng/ml, middle panel). In addition, DN T cells were CFSE-
labeled, cultured with or without IL-21 (200 ng/ml), and proliferation measured by flow cytometry (lower panel). Data are representative of 2-3
independent experiments with 2–5 mice/group. Asterisks indicate statistical significance (p,0.05).
doi:10.1371/journal.pone.0027528.g002
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lpr T cell proliferation and conversion to DN T cells in T cell-deficient recipients. (A) Homeostatic and spontaneous
proliferation. Purified CD4
+, CD8
+, and DN T cells from LNs of 12 week-old MRL-Fas
lpr mice were labeled with CFSE and transfused to TCRb
–/–
recipients. After 7 days, TCRb
+ T cell subsets were harvested from the recipients’ peripheral LNs. Numbers indicate percentage of cells in 0 divisions
(CFSE-high), 1–6 divisions (CFSE-intermediate, mostly homeostatic proliferation), and .7 divisions (CFSE-negative, mostly spontaneous proliferation).
(B) Reduced spontaneous proliferation of CD8
+ T cells in chronically immunodeficient TCRb
–/– MRL-Fas
lpr recipients. Total LN cells from MRL-Fas
lpr
mice were labeled with CFSE, transferred to TCRb
–/– recipients, and CFSE profiles examined 13 days post-transfer in peripheral LNs, mesenteric LNs
and spleen. As controls, LN cells from C57BL/6 mice were CFSE-labeled and transferred to RAG2
–/– C57BL/6 recipients. (C) Conversion of CD8
+ T cells
to DN T cells during spontaneous proliferation. Purified CD4
+ (left panel) and CD8
+ (right panel) LN T cells were CFSE-labeled and transfused to
TCRb
–/– hosts. Gated TCRb
+CD8
– (left panel) and TCRb
+CD4
– (right panel) cells were analyzed 1, 2 or 3 weeks post-transfer for the expression of the
CD4 or CD8 coreceptors, respectively. Numbers represent percentages of T cells that had either retained (0-6 divisions, upper right quadrant; .7
divisions, upper left quadrant), or lost the coreceptor (0-6 divisions, lower right quadrant; .7 divisions, lower left quadrant). Conversion to DN cells
(coreceptor loss) mostly occurred for donor CD8
+ T cells (right panel) after strong proliferation (i.e., of all the cells that had undergone .7 divisions,
77% had lost CD8 expression at 1 week, 82% at 2 weeks, and 51% at 3 weeks). (D) Conversion to DN T cells during spontaneous proliferation is
accompanied by down-regulation of IL-7Ra and IL-2/15Rb. Purified CD8
+ T cells from LNs were CFSE-labeled, transfused into TCRb
–/– hosts, and 12
days post-transfer, gated TCRb
+CD4
– cells were analyzed for the expression of CD8, IL-7Ra and IL-2/15Rb. Data are representative of 2-3 independent
experiments with 3-4 mice/group.
doi:10.1371/journal.pone.0027528.g003
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antibody was effective for up to 4 weeks, with progressive
declines thereafter due to immune response against the
heterologous antibody. Nonetheless, treatment initiated at early
disease stages (6 weeks of age) resulted in significant reductions in
dermatitis, lymphadenopathy, splenomegaly and total serum
IgG2a, and marginal reduction in anti-chromatin IgG2a auto-
antibodies, compared to PBS-injected controls (Figure 6B-6E).
Treated mice also displayed reduced numbers of CD4
+,C D 8
+
and DN T cells, as well as immature (T1) and follicular (T2-F0)
B cells, whereas marginal zone B cells were unaffected
(Figure 6D). The frequency of peritoneal B-1 cells was also
unaffected by this treatment (33.162.5% vs 26.465.3%).
Moreover, as expected on the basis of IL-7R expression, there
were significant reductions in anti-IL-7Ra-treated vs. control
mice at the early developmental stages of bone marrow B cells
[pre-/pro-B cells (5.960.5% vs. 24.461.7%), newly formed B
cells (2.160.4% vs. 4.560.1%) and recirculating B cells
(1.660.2% vs. 3.860.3%)] as well as immature thymocytes
[CD44
+CD25
+ DN-II cells (3.260.3% vs. 6.260.1%) and
TCRb
hiCD69
hi cells (6.360.8% vs. 9.860.2%)].
A separate group of mice was then similarly treated beginning at
14 weeks of age to assess whether IL-7R blockade could inhibit
established disease. Indeed, treatment significantly reduced
proteinuria, glomerulonephritis, and lymphocyte infiltrates in the
kidneys (Figure 6F). Impressively, at 24 weeks of age all antibody-
treated mice were alive, compared to .50% mortality in the
control group (Figure 6G).
Discussion
We performed studies to define homeostatic characteristics of T
cells in the MRL-Fas
lpr lupus model, focusing on potential
imbalances in the production and consumption of the major T
cell prosurvival cytokines. We found that a substantial proportion
of T cells displayed phenotypic markers resembling those of T cells
undergoing homeostatic proliferation. In addition, the DN T cells
that massively accumulate in this Fas-defective lupus model were
found to permanently down-regulate the receptors for IL-7 and
IL-15, probably due to chronic activation in part mediated by
commensal antigens, leading to reduced consumption of these
cytokines. Lymphoaccumulation in these mice was also associated
Figure 4. IL-7 excess in old MRL-Fas
lpr mice. (A) DN T cells (IL-7Ra-negative) do not inhibit homeostatic T cell proliferation. CFSE-labeled T cells
(3610
6) from LNs of young (8 weeks) MRL-Fas
lpr mice were transfused into TCRb
–/– MRL-Fas
lpr recipients alone (control) or together with 50-100610
6
of either total LN T cells (mostly naı ¨ve, lacking DN cells) from young (6 weeks) mice (left panel), or purified DN T cells from older (12 weeks) mice (right
panel). Data represent percentages (6 SD) of cells in various cell divisions as determined by CFSE profile analysis. (B) T cell proliferation in older non-
lymphopenic MRL-Fas
lpr hosts. CFSE-labeled LN T cells (20610
6) from older (16 weeks) MRL-Fas
lpr mice were transferred into age-matched
unmanipulated (non-lymphopenic) wild-type syngeneic recipients. Seven or 15 days after transfer, LN and spleen cells were harvested and donor
CFSE
+ T cells detected by gating the TCRb
+CD4
+ or TCRb
+CD8
+ cell populations. The frequency (6 SD) of donor cells in divisions 0 to 4 was calculated
as a percentage of CFSE
+ cells. (C) No T cell proliferation in young non-lymphopenic MRL-Fas
lpr hosts. The same experiment as in panel B was
performed using young (6 weeks) MRL-Fas
lpr mice as T cell donors and non-lymphopenic recipients. (D) T cell proliferation in non-lymphopenic older
MRL-Fas
lpr hosts is IL-7-dependent. Older MRL-Fas
lpr mice with lymphadenopathy (16 wks of age) were transfused with CFSE-labeled T cells from age-
matched donors and treated with blocking anti-IL-7Ra antibodies three times per week. CFSE proliferation profiles of CD4
+ and CD8
+ T cells were
examined on day 7 post-transfer. Data are representative of 2–3 independent experiments with 3-4 mice/group.
doi:10.1371/journal.pone.0027528.g004
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IL-7-dependent T cell proliferation. Consequently, treatment with
an IL-7Ra-blocking antibody significantly reduced autoimmune
disease manifestations in this model (Figure 7).
We and others have hypothesized that, in predisposed genetic
backgrounds, recurrent homeostatic T cell proliferation triggered by
lymphopenia and excess of T cell-trophic cytokines may be a
contributing factor in the pathogenesis of systemic autoimmunity
[14-17]. This possibility stems from the observation that during
homeostatic proliferation T cells acquire effector functions and are
selected for high affinity to self-antigens [11-13]. Indeed, a
considerable proportion of T cells in MRL-Fas
lpr mice displayed
surface markers comparable to those acquired by normal T cells
during homeostatic proliferation, and similar phenotypic character-
istics have been reported for C57BL/6-Fas
lpr Tc e l l s[ 3 6 ] .A l t h o u g h
this phenotype may also be acquired by conventional antigen-
induced effectors during conversion to central memory T cells, this
seems unlikely since classical T cell activation is associated with
transient expression of CD25 [9,37], yet this marker was primarily
detected on Foxp3
+ regulatory T cells and, at low levels, in a very
small population (,5%) of Foxp3
– CD4
+ Tc e l l s .N o n e t h e l e s s ,a
substantial fraction of CD4
+,C D 8
+ and DN T cells expressed the
CD69 marker, typically upregulated during antigen-induced
activation. Thus, both conventional (self) antigens and homeostatic
proliferation seem to contribute to T cell activation in this model.
The present study indicates that homeostatic T cell proliferation
in these mice is driven by excess of IL-7, since adoptively-
transferred SP T cells proliferated in unmanipulated older MRL-
Fas
lpr recipients, and this proliferation was significantly blocked by
administration of anti-IL-7Ra antibody. Similar observations were
reported for C57BL/6-FasL
gld mice, which also exhibit expansion
of DN T cells with reduced expression of IL-7Ra and IL-2/15Rb
[38]. Two major mechanisms emerge from the present study that
might explain how IL-7 excess is attained in these mice: increased
production due to the expansion of FRCs in the enlarged LNs, and
decreased consumption due to persistent down-regulation of IL-
7Ra by DN T cells.
FRCs constitute a unique type of stromal cells that enwrap
conduits, consisting of collagen fibers and other extracellular
matrix proteins, that distribute lymph and small molecules
throughout the T cell zone of secondary lymphoid organs [4].
FRCs have been identified as the major source of IL-7 and other
factors essential for T cell homeostasis and trafficking [3].
Presumably, lymphoaccumulation of DN T cells induces reorga-
nization of the microarchitecture in the enlarged LNs, leading to
increased FRC numbers, as was reported to occur during LN
organogenesis, or following certain infections that transiently
deplete FRC networks [4].
Regarding the second mechanism, transient down-regulation of
IL-7Ra has been previously shown in thymocytes during transition
Figure 5. Increased IL-7 production and expansion of fibroblastic reticular cells in LNs of old MRL-Fas
lpr mice. (A) Transcript level
analysis. RT-PCR was performed to examine IL-7 and IL-7Ra expression in LNs of young (Y, 6 weeks) and older (O, 20 weeks) MRL-Fas
lpr and control
C57BL/6 (B6) mice. Data were normalized using HPRT1 and expressed as fold change (6 SD) compared to transcript levels in B6 mice. (B) IL-7 protein
levels in young and older MRL-Fas
lpr. Immunoblot was used to determine IL-7 protein levels in LNs of young (Y, 6 weeks) and older (O, 18 weeks) MRL-
Fas
lpr and control C57BL/6 (B6) mice. Data acquired by densitometry were normalized using b-actin and expressed as ford change (6 SD) compared
to IL-7 protein levels in B6 mice. (C) Flow cytometric analysis of fibroblastic reticular cells (FRCs). LN cells of MRL-Fas
lpr and control B6 mice were
stained with antibodies to CD45, gp38 (podoplanin) and CD31. Representative plots showing the frequency of FRCs (CD31
– gp38
+) in the CD45
– LN
cell population are depicted. (D) Accumulation of FRCs and IL-7Ra
+ T cells in MRL-Fas
lpr mice. The number (6 SD) of FRCs and IL-7Ra
+ T cells in LNs of
young and older MRL-Fas
lpr compared to B6 controls was determined by flow cytometry. (E) Accumulation of FRCs is proportional to the number of
total LN cells in MRL-Fas
lpr mice. LN cells were isolated from mice displaying various levels of lymphadenopathy. The numbers of FRCs (CD45
– CD31
–
gp38
+) and IL-7Ra
+ T cells (TCRb
+) were determined by flow cytometry and plotted as a function of the number of total LN cells for each individual
mouse. Linear regression and goodness of fit (r) were calculated using Prism 4 software. Dotted lines indicate the frequency 6 1 STD of FRCs (left
panel) and IL-7Ra
+ T cells (right panel) as determined in young mice before development of lymphadenopathy, and predict how these cell types
would accumulate with disease progression if their frequencies were maintained at a constant. Data are representative of 2–3 independent
experiments with 3–5 mice/group. Asterisks indicate statistical significance (p,0.05).
doi:10.1371/journal.pone.0027528.g005
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lpr mice. (A) IL-7R blockade by anti-IL-7Ra antibody. MRL-Fas
lpr mice (6 weeks old) were
treated with anti-IL-7Ra antibody or PBS, 3 times weekly for 4 weeks, and expression of IL-7Ra was determined. (B–E) Prophylactic anti-IL-7Ra
antibody treatment. Young female MRL-Fas
lpr mice (6 weeks old) were treated with anti-IL-7Ra or PBS for 6 to 10 weeks. Antibody levels (E) were
assessed after 6 weeks, dermatitis (B) after 8 weeks, and weights (6 SD) of inguinal, axillary and cervical LNs and spleen (C) after 10 weeks of
treatment. B and T cell subsets (D) were examined in LNs and spleen after 10 weeks of treatment. (F-G) Therapeutic anti-IL-7Ra antibody treatment.
Female MRL-Fas
lpr mice (14 weeks old) with established disease (lymphadenopathy and anti-chromatin autoantibodies) were treated with anti-IL-7Ra
or PBS for 3 to 10 weeks. Proteinuria, glomerulonephritis (GN) and lymphocytic infiltration (LI) were determined between 14 and 20 weeks of age (E),
and survival at 24 weeks of age (F). Data are representative of 1–5 independent experiments with 3–9 mice/group.
doi:10.1371/journal.pone.0027528.g006
Figure 7. IL-7 excess and systemic autoimmunity in MRL-Fas
lpr mice. The following model is proposed: commensal and self-antigens in MRL-
Fas
lpr lupus mice induce proliferation of CD8
+ T cells and conversion to double-negative (DN) T cells that irriversibly down-regulate IL-7R.
Lymphoaccumulation causes reorganization of the lymphoid organ microarchitecture and expansion of the stromal cell compartment, including
fibroblastic reticular cells (FRCs), the main source of IL-7. The resulting excess of IL-7 is not used by DN cells, but instead promotes autoreactive T cell
activation and proliferation. Consequently, antibody-mediated blockade of IL-7R signaling reduces autoimmunity in this model.
doi:10.1371/journal.pone.0027528.g007
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T cells following either TCR engagement or signaling by IL-7
and other pro-survival cytokines [24]. This transient IL-7Ra
down-regulation is required for efficient IL-7 signaling [39], but
has also been proposed as an ‘‘altruistic’’ mechanism to ensure
availability of this survival-promoting cytokine to unstimulated T
cells [5]. Contrastingly, for the MRL-Fas
lpr DN T cells, down-
regulation of IL-7Ra (and IL-2/15Rb) appears irreversible.
Irreversible down-regulation of IL-7Ra also occurs in functionally
‘‘exhausted’’ T cells that accumulate during persistent viral
infections, such as HIV or LCMV [33,34] and, interestingly, high
levels of IL-7 can be detected in the serum of AIDS patients [33].
Therefore, it is likely that the DN T cells of MRL-Fas
lpr mice have
also reached an exhaustion state, which is further suggested by an
age-related progressive decline in proliferative capacity of these
cells both in vitro and in vivo [31,40]. The molecular mechanism
by which IL-7Ra expression is regulated has not been fully
explained. Nonetheless, IL-7Ra endocytosis is mediated by
clathrin-coated pits followed by Jak3- and proteasome-dependent
degradation [39], while resynthesis is regulated by several factors,
including the transcriptional repressor growth factor indepen-
dence-1 (GFI1) and the transcription factor Forkhead box O1
(Foxo1)[24,41].
Absence of IL-7R and IL-15R in DN T cells raises questions on
the nature of alternative resources utilized by these cells for
survival. We obtained evidence that this function might, in part, be
subserved by IL-21, another prosurvival cytokine for naı ¨ve and
activated/memory T cells [32]. Interestingly, blockade of IL-21
has been reported to reduce the MRL-Fas
lpr disease, including
lymphadenopathy [42], and this cytokine has been shown to
support the survival and function of chronically-activated CD8
+ T
cells during a persistent viral infection [43].
The nature of the activating stimulus that promotes conversion
of CD8
+ precursors to DN T cells has not been directly defined.
However, based on the present adoptive transfer experiments in
chronically immunodeficient recipients, we have hypothesized that
commensal antigens may in part be responsible for driving this
process. Specifically, we found that a) DN T cells exhibited
spontaneous proliferation, which is attributed to microbiota-derived
antigens and DC activation by innate stimuli [19–21], but not
homeostatic proliferation, which is attributed to self-peptide/MHC
recognition [1,2]; b) the CD8
+ T cell repertoire of MRL-Fas
lpr
mice was largely depleted of cells able to undergo spontaneous
proliferation, presumably because of their conversion to DN cells;
and c) the small CD8
+ fraction that displayed spontaneous
proliferation converted to DN T cells and down-regulated IL-
7Ra and IL-2/15Rb. Previous studies indicated that down-
regulation of CD8 may result from sustained antigen stimulation
[44,45], or reduced IL-7 signaling [46], suggesting that down-
regulation of IL-7Ra may precede that of CD8. Moreover, the
small population of DN T cells present in normal mice was
reported to display anti-bacteria specificity [47], and MRL-Fas
lpr
mice bred in a germ-free environment and fed an antigen-free diet
had significant reductions in lymphadenopathy and other disease
characteristics [48]. The findings as a whole suggest that activation
of CD8
+ T cells and conversion to DN cells may, in part, be driven
by commensal rather than self-ligands, likely due to defects in the
anatomic barriers that limit bacterial translocation [49], and/or
defects in the suppressive mechanisms that curtail responses to
these ligands [1]. Adoptive transfer experiments, similar to those
described in the present study, with germ-free MRL-Fas
lpr
recipients will allow more definitive conclusions with regard to
the role of commensal antigens in driving CD8
+ T cell activation
and conversion to DN cells in this model.
Studies with Fas
lpr mice lacking MHC class I, MHC class II,
CD4, or CD8 suggested that CD8
+ T cells and the derivative DN
cells are not essential for autoimmune disease development,
whereas CD4
+ T cells are required [26–31]. Nonetheless, in some
of these studies, mice lacking CD8
+ and DN T cells showed
significant reductions in serologic and histologic disease parame-
ters [28–31]. The present results suggest that DN T cells
contribute to disease indirectly by reducing the cellular ‘‘sinks’’
for IL-7 and promoting expansion of cells that produce this
cytokine. Similar changes may occur in SLE and in autoimmune
lymphoproliferative syndrome (ALPS), where there is expansion of
DN T cells [50–52].
T h eu l t i m a t ee f f e c to fI L - 7e x c e s si na u t o i m m u n i t yi sa
reduction of the activation threshold of autoreactive T cells,
which, when superimposed on a predisposed genetic back-
ground, leads to disease enhancement. Hence, treatment of
MRL-Fas
lpr mice with an IL-7Ra-blocking antibody exerted
significant disease-decreasing effects even when applied at an
advanced disease stage. These effects are compatible with the
primary role of IL-7 in survival and proliferation of naı ¨ve, early
effector, and memory CD4
+ T cells. It is possible, however, that
additional mechanisms may contribute to the therapeutic effects,
including reduction of autoreactive B cells, the development of
which is dependent on IL-7 in mice [5,6]. Moreover, IL-7Ra is
also a component of the thymic stromal lymphopoietin (TSLP)
[53], a cytokine previously shown to promote systemic auto-
immunity when overexpressed in transgenic mice [54]. Thus,
disease reduction in anti-IL-7Ra antibody-treated mice may be
due to inhibition of both IL-7 and TSLP, and additional
experiments with specific antibodies or targeted gene deletion
may clarify the differential contribution of these cytokines in
systemic autoimmunity. Considering that autoimmune disease
pathogenesis invariably involves the participation of CD4
+ T
cells, it is likely that blockade of IL-7Ra signaling will be an
efficient treatment in a wide spectrum of autoimmune and
inflammatory disorders.
Materials and Methods
Mice
Animals were housed in a facility approved by the Association
for Assessment and Accreditation of Laboratory Animal Care
International. All animal experiments and protocols were
performed according to the NIH Guide for the Care and Use of
Laboratory Animals and approved by The Scripps Research
Institute Animal Care Committee (permit numbers 09-0082 and
09-0101). MRL-Fas
lpr, C57BL/6 (B6) and C57BL/6.Rag2
–/– mice
were obtained from The Jackson Laboratory (Bar Harbor, ME),
and T cell-deficient TCRb
–/– MRL-Fas
lpr mice have been
previously described [55]. These mice were maintained at the
mouse facility of The Scripps Research Institute under specific
pathogen-free conditions.
Cell Preparations
Single cell suspensions were prepared from bone marrow,
thymus, spleen and LNs (inguinal, axillary, brachial, cervical and,
when indicated, mesenteric). To analyze B cell precursors in bone
marrow, cells were stained with antibodies to Igk and CD19, and
pre-/pro-B cells (CD19
+ Igk
–), newly formed B cells (CD19
low
Igk
low) and recirculating B cells (CD19
hi Igk
hi) were identified by
flow cytometry. Similarly, flow cytometry was used to enumerate
T cell precursors (DN-I to DN-IV, TCRb
lowCD69
low,
TCRb
hiCD69
hi) upon thymocyte staining with antibodies to
CD4, CD8, CD44, CD25, CD69 and TCRb. To analyze FRCs,
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obtained single cell suspensions were stained with antibodies to
CD45, gp38 (podoplanin) and CD31, and FRCs were identified by
flow cytometry as CD45
–CD31
– gp38
+ cells, as described [3]. For
some in vivo and in vitro experiments, purified CD4
+, CD8
+ and
DN T cell subsets were isolated by cell sorting using monoclonal
antibodies to mouse CD19 and I-A
k (to exclude non-T cells), as
well as CD4 and CD8. As assessed by flow cytometry using
fluorescent antibodies to TCRb, CD4 and CD8, purity was
typically 96–98%.
Flow Cytometry
Monoclonal antibodies to mouse TCRb, CD4, CD8, CD44,
CD25, CD69, CD62L, CD127, CD122, CD132, Foxp3, IL-21R,
pSTAT5, CD19, Igk, CD23, CD21, CD5, B220, gp38 (podopla-
nin), CD31 and CD45, and streptavidin (conjugated to FITC, PE,
PerCP, or APC) were commercially obtained (BD Pharmingen,
Biolegend or eBioscience). For surface staining, cells were
sequentially incubated with various combinations of antibodies
or streptavidin. For detection of Foxp3, fixed cells were
permeabilized and stained with a specific antibody, as recom-
mended by the manufacturer (eBioscience). Cell events were
acquired on four-color FACSCalibur
TM (BD Pharmingen) and
data were analyzed using FlowJo software (Tree Star).
Real Time Quantitative RT-PCR
LN cells were obtained from young (6 wks) and older (20 wks)
MRL-Fas
lpr mice and control C57BL/6 mice (12 wks) (n=3 mice/
group). RNA was extracted from total LN cells (RNeasy Plus Mini
kit, Qiagen) and cDNA synthesized (RT First Strand Kit,
SABiosciences). PCR was performed in triplicate using 400 ng
cDNA, the RT SYBR Green qPCR Master Mix (SABiosciences),
primer sets specific for mouse IL-7, IL-7Ra or HPRT1 gene
sequences (SABiosciences), and an ABI PRISM 7900HT Se-
quence Detection System (PE Biosystems). IL-7 and IL-7Ra
transcript levels in individual mice were normalized using HPRT1
values and expressed as fold change in comparison to levels in
control C57BL/6 (B6) mice.
Immunoblot
LNs were obtained from young (6 wks) and older (18 wks)
MRL-Fas
lpr mice and control C57BL/6 mice (16 wks) (n=3
mice/group). LNs were minced with a razor blade and lysed
overnight at 4uC in M-Per mammalian extraction buffer
containing 150 mM NaCl2 (Thermo Scientific). Protein concen-
trations were determined (Bio-Rad Protein Assay) and, for each
individual mouse, 75 mg separated on a precast 4–12% gradient
polyacrylamide gel (Invitrogen) under reducing conditions.
Proteins were transferred to a nitrocellulose membrane using
Invitrogen iBlot technology and antibody incubation and washes
were performed using an Invotrogen BenchPro 410 card
processing station. Briefly, membranes were incubated with rat
anti-mouse IL-7 monoclonal antibody (R&D Systems) followed
by peroxidase-conjugated goat anti-rat IgG antibody (Jackson
ImmunoResearch Labs) and SuperSignal chemiluminescent
substrate (Thermo Scientific). After film (ThermoScientific)
exposure, nitrocellulose membranes were stripped and re-probed
using a rabbit anti-mouse b-actin antibody (Cell Signaling
Technology) followed by peroxidase-conjugated donkey anti-
rabbit IgG antibody (BioLegend). Films were examined by
densitometry (ImageJ software) and, for each individual mouse,
band intensities were normalized by subtracting the background
and calculating the ratio IL-7/b-actin.
Adoptive Cell Transfers
Total LN cells or purified CD4
+,C D 8
+ and DN T cells from
MRL-Fas
lpr mice were stained with 5,6-carboxyfluorescein
diacetate succinimidyl ester (CFSE, Molecular Probes). Briefly,
cells were washed in PBS containing 0.1% BSA (PBS/
0.1%BSA), resuspended to 10
7 cells/ml in pre-warmed (37uC)
PBS/0.1%BSA containing 10 mM CFSE, incubated for 10 min
at 37uC ,a n dw a s h e do n c ew i t hc o l dD M E Mc o n t a i n i n g2 0 %
FCS and once with cold DMEM. Aliquots of 3 to 20610
6
CFSE-stained cells were injected intravenously (i.v.) into T cell-
deficient (TCRb
–/–) or lymphosufficient (wild-type) MRL-Fas
lpr
recipients. In some experiments, the CFSE-stained cells were
co-injected with 50-100610
6 of unstained total LN cells or
purified DN T cells. At the indicated time points, mice were
sacrificed, and LN and spleen cells were analyzed by flow
cytometry.
In Vitro Studies
Total LN cells or purified DN T cells were cultured in complete
RPMI-1640 (10% FCS, 2 mM L-glutamine, 20 U/ml penicillin,
and 20 mg/ml streptomycin) supplemented with recombinant IL-
7 (20 ng/ml), IL-15 (10 ng/ml) or IL-21 (50, 100 or 200 ng/ml).
At the indicated time-points, cells were harvested, counted, and
the numbers of viable CD4
+,C D 8
+ and DN T cells were
determined on the basis of Trypan Blue exclusion and flow
cytometry analysis. To evaluate IL-7 signaling-inhibition by the
anti-IL-7Ra antibody (A7R34), splenocytes (5610
6) were cultured
for 10 min with recombinant IL-7 (100 ng/ml), anti-IL-7Ra
(10 mg/ml), combinations of IL-7 and anti-IL-7Ra, or medium
alone. Cells were then washed, stained with antibodies to TCRb
and CD4, fixed, permeabilized, intracellularly stained with
antibodies to pSTAT5 (Cell Signaling Technology) and analyzed
by flow cytometry.
In Vivo Treatment with Anti-IL-7Ra Antibodies
MRL-Fas
lpr mice were treated i.p. with 200 mg anti-IL-7Ra rat
monoclonal antibody (clone A7R34) three times per week for 1 to
10 weeks. Treatment was started either before (6 weeks of age) or
after (14 weeks of age) appearance of disease manifestations (i.e.
dermatitis, lymphadenopathy and autoantibody titers).
Serology
Total and anti-chromatin serum IgG subclasses were assessed
by ELISA using 96-well plates coated with goat anti-mouse IgG
(Jackson ImmunoResearch Laboratories) or mouse chromatin,
respectively. Bound antibodies were detected using alkaline
phosphatase-conjugated goat antibodies (Caltag Laboratories) to
mouse IgG or IgG2a, the main autoantibody subclass in this
model. Standard curves were generated using calibrated mouse
serum (Accurate Chemical and Scientific Company).
Kidney Pathology
Levels of proteinuria were determined using reagent strips for
urinalysis (Albustix, Bayer Corporation) and graded semiquanti-
tatively (0 = negative to traces, 1 = 30 mg/ml; 2 = 100 mg/ml,
3 = 300 mg/ml, 4 = 2000 mg/ml). The severity of glomerulo-
nephritis (GN) and lymphocytic infiltrates were scored blindly on a
0–4 scale, as described [56].
Statistical Analysis
Group comparisons were analyzed by unpaired two-tailed
Student’s t test. Survival was analyzed by Kaplan-Meier plot and
log rank test. p,0.05 was considered significant.
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